195 related articles for article (PubMed ID: 27560626)
21. Employment and absenteeism in working-age persons with multiple sclerosis.
Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Thouvenot E; Orsini M; Daures JP; Camu W
Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Stein MS; Liu Y; Gray OM; Baker JE; Kolbe SC; Ditchfield MR; Egan GF; Mitchell PJ; Harrison LC; Butzkueven H; Kilpatrick TJ
Neurology; 2011 Oct; 77(17):1611-8. PubMed ID: 22025459
[TBL] [Abstract][Full Text] [Related]
24. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.
Langer-Gould A; Popat RA; Huang SM; Cobb K; Fontoura P; Gould MK; Nelson LM
Arch Neurol; 2006 Dec; 63(12):1686-91. PubMed ID: 17172607
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal Associations of Modifiable Lifestyle Factors With Positive Depression-Screen Over 2.5-Years in an International Cohort of People Living With Multiple Sclerosis.
Taylor KL; Simpson S; Jelinek GA; Neate SL; De Livera AM; Brown CR; O'Kearney E; Marck CH; Weiland TJ
Front Psychiatry; 2018; 9():526. PubMed ID: 30425659
[No Abstract] [Full Text] [Related]
26. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
[TBL] [Abstract][Full Text] [Related]
27. Pain in People with Multiple Sclerosis: Associations with Modifiable Lifestyle Factors, Fatigue, Depression, Anxiety, and Mental Health Quality of Life.
Marck CH; De Livera AM; Weiland TJ; Jelinek PL; Neate SL; Brown CR; Taylor KL; Khan F; Jelinek GA
Front Neurol; 2017; 8():461. PubMed ID: 28928713
[TBL] [Abstract][Full Text] [Related]
28. Socio-economic, demographic, lifestyle and health characteristics associated with consumption of fatty-sweetened and fatty-salted foods in middle-aged French adults.
Méjean C; Macouillard P; Castetbon K; Kesse-Guyot E; Hercberg S
Br J Nutr; 2011 Mar; 105(5):776-86. PubMed ID: 20946706
[TBL] [Abstract][Full Text] [Related]
29. Association of fish consumption and Ω 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis.
Jelinek GA; Hadgkiss EJ; Weiland TJ; Pereira NG; Marck CH; van der Meer DM
Int J Neurosci; 2013 Nov; 123(11):792-800. PubMed ID: 23713615
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal associations between quality of diet and disability over 7.5 years in an international sample of people with multiple sclerosis.
Simpson-Yap S; Neate SL; Nag N; Probst YC; Yu M; Jelinek GA; Reece JC
Eur J Neurol; 2023 Oct; 30(10):3200-3211. PubMed ID: 37433564
[TBL] [Abstract][Full Text] [Related]
31. Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis.
Moccia M; Palladino R; Carotenuto A; Russo CV; Triassi M; Lanzillo R; Brescia Morra V
Mult Scler Relat Disord; 2016 Nov; 10():90-96. PubMed ID: 27919507
[TBL] [Abstract][Full Text] [Related]
32. Validity of maximal exercise testing in people with multiple sclerosis and low to moderate levels of disability.
Heine M; Hoogervorst EL; Hacking HG; Verschuren O; Kwakkel G
Phys Ther; 2014 Aug; 94(8):1168-75. PubMed ID: 24677255
[TBL] [Abstract][Full Text] [Related]
33. Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients.
Tsivgoulis G; Triantafyllou N; Papageorgiou C; Evangelopoulos ME; Kararizou E; Sfagos C; Vassilopoulos D
Acta Neurol Scand; 2007 Jan; 115(1):67-72. PubMed ID: 17156268
[TBL] [Abstract][Full Text] [Related]
34. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.
Rito Y; Flores J; Fernández-Aguilar A; Escalante-Membrillo C; Barboza MA; Amezcua L; Corona T
Acta Neurol Belg; 2018 Mar; 118(1):47-52. PubMed ID: 28975580
[TBL] [Abstract][Full Text] [Related]
36. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
D'hooghe MB; Haentjens P; Nagels G; De Keyser J
Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
[TBL] [Abstract][Full Text] [Related]
37. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.
Weinstock-Guttman B; Baier M; Park Y; Feichter J; Lee-Kwen P; Gallagher E; Venkatraman J; Meksawan K; Deinehert S; Pendergast D; Awad AB; Ramanathan M; Munschauer F; Rudick R
Prostaglandins Leukot Essent Fatty Acids; 2005 Nov; 73(5):397-404. PubMed ID: 16099630
[TBL] [Abstract][Full Text] [Related]
38. Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
Tettey P; Siejka D; Simpson S; Taylor B; Blizzard L; Ponsonby AL; Dwyer T; van der Mei I
Neuroepidemiology; 2016; 46(2):106-13. PubMed ID: 26784322
[TBL] [Abstract][Full Text] [Related]
39. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
Burt RK; Balabanov R; Han X; Sharrack B; Morgan A; Quigley K; Yaung K; Helenowski IB; Jovanovic B; Spahovic D; Arnautovic I; Lee DC; Benefield BC; Futterer S; Oliveira MC; Burman J
JAMA; 2015 Jan; 313(3):275-84. PubMed ID: 25602998
[TBL] [Abstract][Full Text] [Related]
40. Disability progression in multiple sclerosis: a Tunisian prospective cohort study.
Hentati E; Ben Sassi S; Nabli F; Mabrouk T; Zouari M; Hentati F
Neurol Sci; 2018 May; 39(5):879-884. PubMed ID: 29476286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
